|
US6277975B1
(en)
|
1992-10-23 |
2001-08-21 |
Genetics Institute, Inc. |
Fusions of P-selectin ligand protein and polynucleotides encoding same
|
|
US7223845B2
(en)
|
1998-06-16 |
2007-05-29 |
The Board Of Regents Of The University Of Oklahoma |
Synthetic glycosulfopeptides and methods of synthesis thereof
|
|
US20030143662A1
(en)
|
1998-06-16 |
2003-07-31 |
Cummings Richard D. |
Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
|
|
DE69934890D1
(de)
|
1998-06-16 |
2007-03-08 |
Univ Oklahoma |
Glykosulfopeptide und verfahren zu deren herstellung und deren verwendung
|
|
CN1342085A
(zh)
*
|
1998-10-30 |
2002-03-27 |
遗传研究所有限公司 |
通过p－选择素配体(psgl)拮抗剂抑制细胞素t细胞的分化
|
|
JP2002530425A
(ja)
*
|
1998-11-21 |
2002-09-17 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
炎症を処置する際のコア２ＧｌｃＮＡｃトランスフェラーゼインヒビターの使用
|
|
US6492152B1
(en)
|
1999-06-15 |
2002-12-10 |
The Board Of Regents Of The University Of Oklahoma |
Core 1 β3-galactosyl transferases and methods of use thereof
|
|
US7256171B1
(en)
|
1999-11-20 |
2007-08-14 |
The Regents Of The University Of California |
Use of core 2 G1cNAc transferase inhibitors in treating inflammation
|
|
WO2002022820A1
(en)
*
|
2000-09-12 |
2002-03-21 |
Genetics Institute, Llc |
Inhibition of stenosis or restenosis by p-selectin antagonists
|
|
PL366223A1
(en)
*
|
2000-12-29 |
2005-01-24 |
Bio-Technology General Corp. |
Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
|
|
US7744888B2
(en)
|
2001-08-03 |
2010-06-29 |
Abgenomics Cooperatief U.A. |
Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
|
|
US20040116333A1
(en)
|
2001-08-03 |
2004-06-17 |
Rong-Hwa Lin |
Modulators of P-selectin glycoprotein ligand 1
|
|
AU2003255337A1
(en)
*
|
2002-07-31 |
2004-02-23 |
Kylix B.V. |
Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
|
|
JP4599027B2
(ja)
*
|
2002-10-30 |
2010-12-15 |
東洋水産株式会社 |
Ｌ−セレクチン結合阻害剤
|
|
FI20021989A0
(fi)
*
|
2002-11-06 |
2002-11-06 |
Halina Miller-Podraza |
Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
|
|
US20080182801A1
(en)
|
2003-12-22 |
2008-07-31 |
Btg International Limited |
Core 2 glcnac-t inhibitors
|
|
GB0329667D0
(en)
|
2003-12-22 |
2004-01-28 |
King S College London |
Core 2 GlcNAc-T inhibitor
|
|
GB0513881D0
(en)
|
2005-07-06 |
2005-08-10 |
Btg Int Ltd |
Core 2 GLCNAC-T Inhibitors III
|
|
MY148646A
(en)
|
2004-05-10 |
2013-05-15 |
Abgenomics Cooperatief Ua |
Anti-psgl-1 antibodies
|
|
BRPI0510561A
(pt)
|
2004-05-11 |
2007-11-20 |
Abgenomics Corp |
epìtopos que induzem morte de célula t
|
|
GB0513888D0
(en)
|
2005-07-06 |
2005-08-10 |
Btg Int Ltd |
Core 2 GLCNAC-T Inhibitors II
|
|
GB0513883D0
(en)
|
2005-07-06 |
2005-08-10 |
Btg Int Ltd |
Diagnosis of Atherosclerosis
|
|
US20070298034A9
(en)
*
|
2005-12-09 |
2007-12-27 |
Angela Widom |
Sulfotyrosine specific antibodies and uses therefor
|
|
JP5331293B2
(ja)
*
|
2006-04-28 |
2013-10-30 |
公益財団法人野口研究所 |
多様性を表現するオリゴ糖またはその誘導体
|
|
DK2321235T3
(da)
*
|
2008-09-02 |
2019-06-24 |
Construction Research & Technology Gmbh |
Anvendelse af en hærdningsacceleratorsammensætning indeholdende plastificeringsmiddel
|
|
AU2010310122B2
(en)
*
|
2009-10-21 |
2014-05-22 |
Eth Zurich |
Medical utility of glycan-binding proteins and glycans
|
|
EP2718325A4
(en)
|
2011-06-13 |
2015-03-11 |
ABGENOMICS COöPERATIEF U A |
ANTI-PSGL-1 ANTIBODIES AND USES THEREOF
|
|
KR20250159733A
(ko)
|
2017-01-11 |
2025-11-11 |
브리스톨-마이어스 스큅 컴퍼니 |
Psgl-1 길항제 및 그의 용도
|
|
PE20250933A1
(es)
|
2017-03-14 |
2025-04-02 |
Five Prime Therapeutics Inc |
Anticuerpos de union a vista a ph acido
|
|
SG11202008593PA
(en)
|
2018-03-21 |
2020-10-29 |
Five Prime Therapeutics Inc |
ANTIBODIES BINDING TO VISTA AT ACIDIC pH
|
|
AU2019301120A1
(en)
|
2018-07-11 |
2021-02-25 |
Bristol-Myers Squibb Company |
Antibodies binding to VISTA at acidic pH
|